| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Ginkgo Bioworks
|
Yes | Post-IPO Equity |
Bill & Melinda Gates Foundation
|
Yes | Series A |
Aju IB Investment
|
- | Series C |
|
|
- | Series C |
|
|
- | Series C |
Atlas Venture
|
- | Series C |
CLI Ventures
|
- | Series C |
Daphne Teo
|
- | Series C |
|
|
- | Series C |
New Enterprise Associates
|
- | Series C |
OrbiMed
|
- | Series C |
Perceptive Advisors
|
- | Series C |
|
|
- | Series C |